Christopher U. Missling
President and CEO at Anavex Life Sciences Corp.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Anavex Life Sciences Corp., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Anavex Life Sciences Corp. June 10, 202593.3%
-
Anavex Life Sciences Corp. June 18, 202489.3%
-
Anavex Life Sciences Corp. May 23, 202392.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 11, 2025 | Anavex Life Sciences Corp. | Option exercise | +187,500 | $5.04 | $945,000 |
| Sep 11, 2025 | Anavex Life Sciences Corp. | Shares withheld for tax | −145,048 | $9.58 | $1,389,560 |
| Mar 24, 2025 | Anavex Life Sciences Corp. | Option exercise | +500,000 | $0.92 | $460,000 |
| Mar 24, 2025 | Anavex Life Sciences Corp. | Shares withheld for tax | −282,497 | $9.63 | $2,720,446 |
| Mar 28, 2024 | Anavex Life Sciences Corp. | Option exercise | +73,380 | $1.32 | $96,862 |
| Mar 28, 2024 | Anavex Life Sciences Corp. | Open-market sale | −73,380 | $5.11 | $374,972 |
| Jun 29, 2023 | Anavex Life Sciences Corp. | Option exercise | +232,000 | $1.60 | $371,200 |
| Jun 28, 2023 | Anavex Life Sciences Corp. | Option exercise | +268,000 | $1.60 | $428,800 |
| Jun 28, 2023 | Anavex Life Sciences Corp. | Open-market sale | −268,000 | $7.98 | $2,138,640 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.